振德醫療(603301.SH)2019年淨利預增20%到30%
格隆匯1月20日丨振德醫療(603301.SH)發佈2019年度業績預告,預計2019年度實現歸屬於上市公司股東的淨利潤為1.56億元到1.69億元,與上年同期相比,預計將增加2610萬元到3910萬元,同比增加20%到30%。預計2019年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤為1.06億元到1.16億元,與上年同期相比,預計將增加957萬元到1927萬元,同比增加10%到20%。
報告期內,公司不斷拓展海外市場和深耕國內市場,實現銷售收入增長,特別是國內市場銷售收入繼續保持快速增長,帶動公司業績增長。同時,公司2019年度收購蘇州美迪斯醫療運動用品有限公司70%股權和英國Rocialle Healthcare Limited 55%股權,並分別於2019年2月和8月納入公司合併報表範圍,對公司業績產生積極影響。公司2019年度收到政府補助較2018年度增長較多,促進了公司2019年度歸屬於上市公司股東的淨利潤增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.